Omar A. Alaber
University Hospitals of Cleveland
Internal medicineRadiologySurgeryOncologyAdverse effectEndoscopic submucosal dissectionBarrett's esophagusEndoscopic mucosal resectionDiseaseEsophageal cancerMetforminEosinophilic esophagitisType 2 Diabetes MellitusMulticenter studyEsophageal adenocarcinomaIn patientNational databaseConfidence intervalMedicineGastroenterology
29Publications
1H-index
5Citations
Publications 28
Newest
#1Lady Katherine Mejia Perez (Cleveland Clinic)H-Index: 3
#2Dennis Yang (UF: University of Florida)H-Index: 21
Last. Neal Mehta (Cleveland Clinic)H-Index: 4
view all 19 authors...
Background The difference in clinical outcomes after endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for early Barrett's esophagus (BE) neoplasia remains unclear. We compared the recurrence/residual tissue rates, resection outcomes, and adverse events after ESD and EMR for early BE neoplasia. null null null null Methods We included patients who underwent EMR or ESD for BE-associated high grade dysplasia (HGD) or T1a esophageal adenocarcinoma (EAC) at eight academic ...
Source
#1Omar A. AlaberH-Index: 1
#2Apoorva K. ChandarH-Index: 16
Last. Aman RajpalH-Index: 7
view all 7 authors...
Source
Source
#1Samuel Han (The Ohio State University Wexner Medical Center)H-Index: 11
#2Furqan A. Bhullar (Johns Hopkins University)
view all 18 authors...
Background and study aims Endoscopic ultrasound (EUS)-guided tissue sampling is the standard of care for diagnosing solid pancreatic lesions. While many two-way comparisons between needle types have been made in randomized controlled trials (RCTs), it is unclear which size and type of needle offers the best probability of diagnosis. We therefore performed a network meta-analysis (NMA) to compare different sized and shaped needles to rank the diagnostic performance of each needle. Methods We sear...
Source
Source
Source
Source
#1Omar A. AlaberH-Index: 1
#2Apoorva K. ChandarH-Index: 16
Last. Aman RajpalH-Index: 7
view all 5 authors...
Introduction: T2DM and HIV independently confer an increased risk of CV adverse events. We aimed to evaluate the effect of newer oral antidiabetic medications (GLP-1 RA/SGLT2i) on CV outcomes in adults with HIV and T2DM. Methods: Using a national database (IBM Explorys Solutions, IBM, Inc.), we searched for cases (HIV + T2DM patients on GLP-1 RA/SGLT2i and metformin) and controls (HIV + T2DM patients on metformin alone). We calculated comparative odds ratios (OR) and 95% confidence interval (CI)...
Source
#1Omar A. AlaberH-Index: 1
#2Apoorva K. ChandarH-Index: 16
Last. Aman RajpalH-Index: 7
view all 5 authors...
Introduction: Hypoglycemia has been linked to increased cardiovascular (CV) events, however there is limited data about frequency of hypoglycemic episodes and CV outcomes. We aimed to evaluate the association of frequent hypoglycemic episodes (> 5/year) with incident CV events in adults with type 2 diabetes mellitus (T2DM). Methods: We queried a national database (IBM Explorys Solutions, IBM, Inc.) for adults with T2DM who had >5 hypoglycemic episodes (cases) vs. 1 to 5 hypoglycemic episodes (co...
Source
#1Ravi S. ShahH-Index: 1
#2Omar A. AlaberH-Index: 1
Last. Amit BhattH-Index: 14
view all 9 authors...
Source